Gene therapy with your own stem cells for early type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new gene therapy that uses your own blood stem cells to treat type 1 diabetes soon after diagnosis. It aims to see if this treatment can help preserve your body's ability to make insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 40 years old
- You were diagnosed with type 1 diabetes within the last 6 months and started insulin within that time
- You have at least 2 type 1 diabetes autoantibodies (signs the immune system attacks the pancreas)
- Your blood sugar levels (HbA1c) are between 53 and 150 mmol/mol
- Your body still makes some insulin (measurable C-peptide levels)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving your own regulatory T cells (a type of immune cell) back to you can help slow or stop the immune attack on your pancreas in type 1 diabetes. It is for people aged 8 to 65 who still make some insulin.
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
This early-stage trial tests a new type of immune cell therapy (CAR-T cells) designed to stop the body's immune system from attacking insulin-producing cells in type 1 diabetes. The goal is to help preserve remaining pancreas function in people with early-stage disease.
This trial tests a new combination treatment for children who have been diagnosed with stage 1 type 1 diabetes, meaning they have some markers but do not yet need insulin. The treatment uses special immune cells (Treg cells) and an antibody (anti-CD20) to try to preserve the body's ability to make insulin.
This trial is testing a one-time cell treatment (CARC-101C) for people recently diagnosed with type 1 diabetes. The goal is to see if it is safe and can help preserve the body's ability to make some insulin.
This trial tests a new cell injection (CNK-UT009) for adults with type 1 diabetes. The goal is to see if it can help manage blood sugar and reduce insulin needs.
Hear when a new Diabetes, Type I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.